Skip to content

Effect of injection of PRP at Jiaji point on postherpetic neuralgia

Effect of injection of PRP at Jiaji point on postherpetic neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056059
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-03-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Experimental group:Jiaji point injection (lidocaine hydrochloride injection + vitamin B12) combined with Jiaji point injection of PRP once

Sponsors

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who met the above diagnostic criteria and still had pain 3 months after the herpes zoster lesions subsided and were excluded from pain caused by other diseases; 2. The age range was 50-80 years; 3. No serious systemic diseases, stable vital signs, no bleeding tendency; 4. Willing to receive PRP treatment; 5. No treatment measures were taken for PHN within 1 week; 6. Patients who can read and understand by themselves.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients who had used corticosteroids or immunosuppressants within one month, Severe coagulation disorder or ongoing anticoagulation therapy, severe liver and kidney insufficiency, history of severe cardiopulmonary disease, had a history of drug abuse; 3. Allergic constitution, or scar constitution, or patients with infectious skin diseases in the past; 4. Inability to complete self-assessment of intelligence.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale (NRS);Dosage of gabapentin at each time point;

Secondary

MeasureTime frame
DLQI;PSQI;HAMD;

Countries

China

Contacts

Public ContactZhang zhongzhao

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

zhangzz818@163.com+86 15286090061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026